Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiahui Chen

Showing results (661-670 of 712) with videos related to

Pageof 72
Sort By:
The Journal of Organic Chemistry|May 25, 2019
Synthesis of a CGRP Receptor Antagonist via an Asymmetric Synthesis of 3-Fluoro-4-aminopiperidineCarmela Molinaro, Eric M Phillips, Bangping Xiang, et al.
Plos Genetics|February 13, 2018
The rate and potential relevance of new mutations in a colonizing plant lineageMoises Exposito-Alonso, Claude Becker, Verena J Schuenemann, et al.
ACS Nano|January 30, 2020
Continuous Curvature Change into Controllable and Responsive Onion-like Vesicles by Rigid Sphere-Rod AmphiphilesJiancheng Luo, Tong Liu, Kun Qian, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2025
Substantial planar plastic anisotropy in inorganic Mg<sub>3</sub>Bi<sub>2</sub> single crystalsTianyu Zhang, Jin Yan, Jin Ke, et al.
International Immunopharmacology|April 23, 2022
A randomized, crossover, phase I clinical study to evaluate bioequivalence and safety of tofacitinib and Xeljanz® in Chinese healthy subjectsZhongnan Xu, Yanli Wang, Zhengzhi Liu, et al.
ACS Pharmacology & Translational Science|March 20, 2025
Development of a Novel <sup>18</sup>F-Labeled Radioligand for Imaging Cholesterol 24-Hydroxylase with Positron Emission TomographyJian Rong, Chunyu Zhao, Ahmad F Chaudhary, et al.
Cell & Bioscience|June 12, 2019
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domainsYiwen Hu, Xinhuai Dong, Zhenjian He, et al.
Nature Communications|March 4, 2026
Inhibiting Mrt4-rRNA interaction with fumaramidmycin-based derivatives as an antifungal strategyHongxuan Cao, Jie Tu, Jiahui Chen, et al.
Expert Review of Clinical Pharmacology|March 8, 2023
Comparing the bioequivalence and safety of liraglutide in healthy Chinese subjects: an open, single-dose, randomized, repeated, two-sequence, two-cycle phase I clinical trialZhongnan Xu, Zhengzhi Liu, Yanli Wang, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 21, 2024
Pharmacokinetics and safety of a new generic lurasidone: a phase I bioequivalence study in healthy Chinese subjectsZhengzhi Liu, Jinling Xue, Qiaohuan Deng, et al.
Pageof 72

Showing results (661-670 of 712) with videos related to

Sort By:
Pageof 72
The Journal of Organic Chemistry|May 25, 2019
Synthesis of a CGRP Receptor Antagonist via an Asymmetric Synthesis of 3-Fluoro-4-aminopiperidineCarmela Molinaro, Eric M Phillips, Bangping Xiang, et al.
Plos Genetics|February 13, 2018
The rate and potential relevance of new mutations in a colonizing plant lineageMoises Exposito-Alonso, Claude Becker, Verena J Schuenemann, et al.
ACS Nano|January 30, 2020
Continuous Curvature Change into Controllable and Responsive Onion-like Vesicles by Rigid Sphere-Rod AmphiphilesJiancheng Luo, Tong Liu, Kun Qian, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2025
Substantial planar plastic anisotropy in inorganic Mg<sub>3</sub>Bi<sub>2</sub> single crystalsTianyu Zhang, Jin Yan, Jin Ke, et al.
International Immunopharmacology|April 23, 2022
A randomized, crossover, phase I clinical study to evaluate bioequivalence and safety of tofacitinib and Xeljanz® in Chinese healthy subjectsZhongnan Xu, Yanli Wang, Zhengzhi Liu, et al.
ACS Pharmacology & Translational Science|March 20, 2025
Development of a Novel <sup>18</sup>F-Labeled Radioligand for Imaging Cholesterol 24-Hydroxylase with Positron Emission TomographyJian Rong, Chunyu Zhao, Ahmad F Chaudhary, et al.
Cell & Bioscience|June 12, 2019
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domainsYiwen Hu, Xinhuai Dong, Zhenjian He, et al.
Nature Communications|March 4, 2026
Inhibiting Mrt4-rRNA interaction with fumaramidmycin-based derivatives as an antifungal strategyHongxuan Cao, Jie Tu, Jiahui Chen, et al.
Expert Review of Clinical Pharmacology|March 8, 2023
Comparing the bioequivalence and safety of liraglutide in healthy Chinese subjects: an open, single-dose, randomized, repeated, two-sequence, two-cycle phase I clinical trialZhongnan Xu, Zhengzhi Liu, Yanli Wang, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 21, 2024
Pharmacokinetics and safety of a new generic lurasidone: a phase I bioequivalence study in healthy Chinese subjectsZhengzhi Liu, Jinling Xue, Qiaohuan Deng, et al.
Pageof 72